Freenome
Healthcare Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Thane Rd, Nottingham, Nottinghamshire, N...Phone Number
+44 1157840501Website
www.earlycdt.comRevenue
<$5 MillionIndustry
About Freenome
Is Freenome your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Freenome had a recent Job posting/layoffs
Product Launch: Get notified when Freenome launches new products
Freenome, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Freenome is spiking on competitors!
Check if Freenome has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Freenome
Funding: Get notified immidiatlly once Freenome has new funding data
Earning: See what the market has to say on Freenome recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Freenome as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Freenome is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Freenome is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Freenome.
Freenome Tech Stack
A closer look at the technologies used by Freenome
Top Healthcare Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Freenome
Freenome Ltd. specializes in early lung cancer detection through its EarlyCDT Lung test, which utilizes proprietary autoantibody technology to identify early signs of cancer via a standard blood test. The test is designed for high-risk individuals and those with indeterminate pulmonary nodules, aiding in the assessment of lung cancer risk. The effe... Read More